90 related articles for article (PubMed ID: 2035963)
1. Plasma cell myeloma: biology and treatment.
Bergsagel DE
Annu Rev Med; 1991; 42():167-78. PubMed ID: 2035963
[TBL] [Abstract][Full Text] [Related]
2. Multiple myeloma and other differentiated B-cell disorders.
Giles FJ
Curr Opin Hematol; 1994 Jul; 1(4):278-84. PubMed ID: 9371294
[TBL] [Abstract][Full Text] [Related]
3. Biology and treatment of multiple myeloma.
Tosi P; Gamberi B; Giuliani N
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):81-6. PubMed ID: 16399590
[TBL] [Abstract][Full Text] [Related]
4. [Plasma cell myeloma. I. A new concept of disease biology].
Barlogi B; Epstein J; Selvaniagam P; Alexanian R
Gematol Transfuziol; 1991 Aug; 36(8):29-35. PubMed ID: 1752407
[No Abstract] [Full Text] [Related]
5. Treatment of multiple myeloma.
San Miguel JF; Bladé Creixenti J; García-Sanz R
Haematologica; 1999 Jan; 84(1):36-58. PubMed ID: 10091392
[TBL] [Abstract][Full Text] [Related]
6. [Diagnosis and therapy of multiple myeloma: current aspects].
Betticher DC; Cerny T; Fey MF
Schweiz Med Wochenschr; 1995 Mar; 125(11):541-51. PubMed ID: 7899848
[TBL] [Abstract][Full Text] [Related]
7. Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma.
Rajkumar S; Fonseca R; Lacy M; Witzig T; Lust J; Greipp P; Therneau T; Kyle R; Litzow M; Gertz M
Bone Marrow Transplant; 1999 Sep; 24(5):497-503. PubMed ID: 10482933
[TBL] [Abstract][Full Text] [Related]
8. [Multiple myeloma: a proper selection of the treatment regimen for an individual patient].
Kanoh T
Nihon Rinsho; 1995 Mar; 53(3):671-7. PubMed ID: 7699903
[TBL] [Abstract][Full Text] [Related]
9. Maintenance treatment with recombinant alpha interferon after autologous bone marrow transplantation for aggressive myeloma in first remission after conventional induction chemotherapy.
Attal M; Huguet F; Schlaifer D; Payen C; Lassoued S; Laroche M; Rossi JF; Fournie B; Mazieres B; Pris J
Bone Marrow Transplant; 1991 Aug; 8(2):125-8. PubMed ID: 1933053
[TBL] [Abstract][Full Text] [Related]
10. Early harvest and late transplantation as an effective therapeutic strategy in multiple myeloma.
Gertz MA; Lacy MQ; Inwards DJ; Chen MG; Pineda AA; Gastineau DA; Greipp PR; Lust JA; Tefferi A; Witzig TE; Kyle RA; Litzow MR
Bone Marrow Transplant; 1999 Feb; 23(3):221-6. PubMed ID: 10084252
[TBL] [Abstract][Full Text] [Related]
11. [Multiple myeloma--advances in disease biology and implications for therapy].
Chou T
Gan To Kagaku Ryoho; 2001 Sep; 28(9):1206-12. PubMed ID: 11579631
[TBL] [Abstract][Full Text] [Related]
12. Using genomics to identify high-risk myeloma after autologous stem cell transplantation.
Shaughnessy JD; Barlogie B
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):77-80. PubMed ID: 16399589
[TBL] [Abstract][Full Text] [Related]
13. Etiology of multiple myeloma: what's new.
Berenson JR
Semin Oncol; 1999 Oct; 26(5 Suppl 13):2-9. PubMed ID: 10528889
[TBL] [Abstract][Full Text] [Related]
14. Multiple myeloma: recognition and management.
George ED; Sadovsky R
Am Fam Physician; 1999 Apr; 59(7):1885-94. PubMed ID: 10208707
[TBL] [Abstract][Full Text] [Related]
15. Biology of plasma cells.
Chen-Kiang S
Best Pract Res Clin Haematol; 2005; 18(4):493-507. PubMed ID: 16026733
[TBL] [Abstract][Full Text] [Related]
16. Aggressive plasma cell myeloma. A terminal phase.
Suchman AL; Coleman M; Mouradian JA; Wolf DJ; Saletan S
Arch Intern Med; 1981 Sep; 141(10):1315-20. PubMed ID: 7271406
[TBL] [Abstract][Full Text] [Related]
17. [Immunology of myeloma].
Bataille R; Klein B; Rossi JF
Nouv Rev Fr Hematol (1978); 1987; 29(4):255-64. PubMed ID: 3320951
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of myeloma.
Anderson KC; Carrasco RD
Annu Rev Pathol; 2011; 6():249-74. PubMed ID: 21261519
[TBL] [Abstract][Full Text] [Related]
19. Unusual evolution of Waldenström's macroglobulinemia into osteolytic myeloma.
Jondeau K; Alterescu R; Franc B; Davi F; Massé JM; Boukour S; Le Parc JM; Cramer EM
Eur J Haematol; 2006 Jul; 77(1):74-9. PubMed ID: 16827885
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in multiple myeloma: practicability for clinical practice and future perspectives.
Haferlach T; Löffler H
Leukemia; 1997 Dec; 11 Suppl 5():S5-9. PubMed ID: 9436931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
